Literature DB >> 8605637

Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia-cardiac iron overload model.

P Liu1, M Henkelman, J Joshi, P Hardy, J Butany, M Iwanochko, M Clauberg, M Dhar, D Mai, S Waien, N Olivieri.   

Abstract

OBJECTIVE: To determine whether nuclear magnetic resonance (NMR) relaxation parameters can be used to quantify iron in tissues, the relationship between NMR spectrometric T2 relaxation measurements and tissue iron concentration were verified in a novel murine cardiac iron overload model.
METHODS: Congenital heterozygous thalassemic mice and controls were injected with intraperitoneal iron or saline and were sacrificed at three weeks. Samples of liver, heart and peripheral muscle were subjected to NMR relaxation measurements and continuous distribution analysis. Tissue ferritin levels were determined with immunoadsorbance techniques, and elemental iron was assayed by flame atomic absorption. Tissues were analyzed pathologically with hematoxylin and eosin and Prussian blue staining to confirm the localization of iron.
RESULTS: This murine iron loading model was uniquely successful in loading iron into the major organs, especially the heart, and produced significant reductions in T1 and T2 NMR relaxation values. There was a good correlation between soluble ferritin and total iron levels (r=0.92), indicating that there is a constant and significant fraction of total iron present in ferritin irrespective of absolute iron concentrations. Regression analysis between total iron content and T2 relaxivity showed a linear relationship (r=0.96), suggesting that the T2 relaxation parameter is related to tissue iron concentration. The regression relationship suggested that NMR can detect iron levels as low as 0.1 mg/g of tissue.
CONCLUSIONS: Parenteral iron loading in mice produces unique iron overload in major organs, including the heart. Local iron deposition is detectable by NMR relaxometry at 0.1 mg/g or higher. There is a linear relationship between iron concentration and T2 relaxivity. Thus, NMR may be an important and useful clinical tool to quantify iron excess in various pathobiological states of human disease due to iron overload, including heart disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605637

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  13 in total

1.  Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload.

Authors:  P D Jensen; F T Jensen; T Christensen; L Heickendorff; L G Jensen; J Ellegaard
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.310

2.  Improved R2* measurements in myocardial iron overload.

Authors:  Nilesh R Ghugre; Cathleen M Enriquez; Thomas D Coates; Marvin D Nelson; John C Wood
Journal:  J Magn Reson Imaging       Date:  2006-01       Impact factor: 4.813

3.  On T2* magnetic resonance and cardiac iron.

Authors:  John-Paul Carpenter; Taigang He; Paul Kirk; Michael Roughton; Lisa J Anderson; Sofia V de Noronha; Mary N Sheppard; John B Porter; J Malcolm Walker; John C Wood; Renzo Galanello; Gianluca Forni; Gualtiero Catani; Gildo Matta; Suthat Fucharoen; Adam Fleming; Michael J House; Greg Black; David N Firmin; Timothy G St Pierre; Dudley J Pennell
Journal:  Circulation       Date:  2011-03-28       Impact factor: 29.690

4.  Mechanisms of tissue-iron relaxivity: nuclear magnetic resonance studies of human liver biopsy specimens.

Authors:  Nilesh R Ghugre; Thomas D Coates; Marvin D Nelson; John C Wood
Journal:  Magn Reson Med       Date:  2005-11       Impact factor: 4.668

5.  The reproducibility of cardiac and liver T2* measurement in thalassemia major using two different software packages.

Authors:  Sophie Mavrogeni; Konstantinos Bratis; Kees van Wijk; Louisa Kyrou; Antonios Kattamis; Johan H C Reiber
Journal:  Int J Cardiovasc Imaging       Date:  2013-08-20       Impact factor: 2.357

6.  Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

Authors:  John C Wood; Maya Otto-Duessel; Michelle Aguilar; Hanspeter Nick; Marvin D Nelson; Thomas D Coates; Harvey Pollack; Rex Moats
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

7.  Magnetic resonance evaluation of liver and myocardial iron deposition in thalassemia intermedia and b-thalassemia major.

Authors:  Sophie Mavrogeni; Efstathios Gotsis; Vassilios Ladis; Eleni Berdousis; Dimitrios Verganelakis; Panagiotis Toulas; Dennis V Cokkinos
Journal:  Int J Cardiovasc Imaging       Date:  2008-06-26       Impact factor: 2.357

8.  Mimicking liver iron overload using liposomal ferritin preparations.

Authors:  John C Wood; Joe D Fassler; Tom Meade
Journal:  Magn Reson Med       Date:  2004-03       Impact factor: 4.668

9.  Usefulness of pulsed wave tissue doppler imaging in assessment of left ventricular functions in children with beta-thalassemia major.

Authors:  Ahmed Mahmoud Abdelmoktader; Hany Younan Azer
Journal:  Indian J Pediatr       Date:  2013-04-19       Impact factor: 1.967

10.  Effect of iron overload on exercise capacity in thalassemic patients with heart failure.

Authors:  Sophie Mavrogeni; Efstathios Gotsis; Dimitrios Verganelakis; Eleni Berdousis; Athanasios Dritsas; Genovefa Kolovou; Panagiotis Toulas; Vassilios Ladis
Journal:  Int J Cardiovasc Imaging       Date:  2009-08-13       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.